$NOC

Key facts: Northrop Grumman (NOC) Q3; B-21 rates up, $2.5B; 50 sats/6mo

Northrop Grumman (NOC) reported Q3 revenue of $11.12B (+7% YoY), net income of $1.124B, and EPS of $7.89. Bookings were $16.4B with a backlog of ~$110B and a book-to-bill ratio of 1.5. The company raised its 2026 adjusted EPS outlook, completed the IMS divestiture, and plans to increase B-21 production rates with a $2.5B investment. It also aims to deploy 50 of 150 Space Systems satellites within six months.

Original reporting
Published Oct 21, 2026, 7:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 7:42 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Key facts: Northrop Grumman (NOC) Q3; B-21 rates up, $2.5B; 50 sats/6mo — source image
Decision brief

The 30-second read

$NOCBullishHigh
01

Why it matters

The earnings beat and guidance raise could drive short-term price appreciation, while the investment signals longer-term growth.

02

Market read

Strong earnings and new investment make NOC a near-term buying opportunity.

03

What to watch

Potential supply-chain constraints for satellite production and future defense budget uncertainties.

Relevance 8/10Novelty 8/10Timing: pre-market today

Background

Northrop Grumman reported Q3 results and announced increased B-21 production and a $2.5B capacity investment.

Company-level read

Ticker impact

$NOCBullishHigh confidence
Context

Q3 earnings released with revenue $11.12B, EPS $7.89 and raised 2026 EPS outlook, plus a $2.5B capacity investment.

Expected impact

likely upward pressure as market prices in stronger earnings and new investment plan

Evidence & confidence

Revenue and EPS beat expectations; guidance lift and large investment indicate stronger future cash flow.

Market effects

Defense and aerospace sector may see broader rally on strong earnings from a major contractor.

U.S. defense stocks could benefit; limited impact outside North America.

Highlights continued U.S. defense spending, modest global relevance.

Counterpoint

Investors may be cautious if the earnings beat is already priced in or if higher investment spending pressures margins.

Key entities

  • Northrop Grumman

    U.S. defense and aerospace contractor.

Related articles

$NOCMed

Plans firm up for local solid rocket motor production

Australia plans to locally produce solid rocket motors (SRMs) with Northrop Grumman, backed by $126.9 million in initial funding. The SRMs will be used in Lockheed Martin's Guided Multiple Launch Rocket System (GMLRS). Northrop Grumman aims to begin industry engagements for local suppliers, with a 2030 deadline for production. A test flight of an Australian-made SRM was successful in August, developed with Thales.

$NOCMedAI 8/10

Northrop Grumman Corp (NOC) (Q3 2026) Earnings Call Highlights: Record $110 Billion Backlog

Northrop Grumman (NOC) reported a record $110 billion backlog. CEO Kathy Warden and CFO John Greene discussed 2027 growth outlook (5-7%), driven by programs like B-21, Sentinel, and international sales. They mentioned potential strategic moves for the microelectronics business. Free cash flow is expected to rise to $3.3B-$3.7B in 2027, supported by sales growth and margin expansion. All segments are projected to grow, with Defense Systems nearing 10% growth.

$NOCHighAI 8/10

Northrop Grumman Corp (NOC) (Q3 2026) Earnings Call Highlights:

Northrop Grumman (NOC) reported Q3 2026 revenue of $11.1B (+7% YoY) with record backlog of $110B (+20% YoY). EPS grew 3% to $7.89. Adjusted free cash flow rose 40% to $1.8B. Guidance raised for full-year EPS and segment operating income. 2027 outlook projects 5-7% sales growth with margin expansion. B-21 program and international sales are key growth drivers. Microelectronics business under strategic review.